Stanford Cancer Center ( Site 0024) — Palo Alto, California

Public research footprint of Stanford Cancer Center ( Site 0024), compiled from the ClinicalTrials.gov public registry.

126

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Metastatic Castration-resistant Prostate Cancer (mCRPC) · Ann Arbor Stage II Diffuse Large B-Cell Lymphoma

Recently updated registry entries

NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT07174336 — A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stanford Cancer Center ( Site 0024)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.